Evidence map›Paper›PMID 41890562›Full record

ArticleJAC-antimicrobial resistance2026

In a bind: a quality improvement project for reducing fluoroquinolones drug-drug interactions with multivalent cations.

Emily A Siegrist, Steven J Pan, Maria Alkozah, Danh Doan, Bryan P White

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily A SiegristDepartment of Pharmacy, OU Health, Oklahoma City, OK, USA.
Steven J PanBiostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Maria AlkozahInfectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID https://orcid.org/0000-0002-7274-5453
Danh DoanDepartment of Pharmacy, OU Health, Oklahoma City, OK, USA.
Bryan P WhiteDepartment of Pharmacy, OU Health, Oklahoma City, OK, USA.ORCID https://orcid.org/0000-0001-5657-7069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Fluoroquinolone (FQ) co-administration with multivalent cations can decrease the bioavailability of the FQ significantly. This interaction is an independent risk factor for FQ resistance, which is a concern as more clinical trials and guidelines support routine use of oral antimicrobials. Methods: We examined the incidence of FQ drug-drug interactions (DDIs) in a quality improvement study after implementation of a bundle of interventions including nursing education, updated medication administration record (MAR) comments and new administration times. Results: In the subgroup of patients ( Conclusion: The bundle of interventions decreased but did not eliminate the interaction. With the interaction as an independent risk factor for resistance and increasing use of oral antibiotics, stewardship programmes should consider implementing similar interventions.

Identifiers

PMID41890562
PMCPMC13014070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.